Stanoxyl 10 mg is an oral stanozolol tablet manufactured by Kalpa Pharmaceuticals and dosed at 10 mg per tablet, supplied in packs of 100 tablets.
Stanoxyl 10 mg contains stanozolol, a synthetic 17-alpha-alkylated oral anabolic-androgenic steroid derived from dihydrotestosterone. Stanozolol is one of the most commonly referenced oral compounds in non-medical bodybuilding contexts for lean muscle retention and strength without water retention. It was originally approved by the FDA in 1962 but is no longer approved for human use in the United States.
In clinical practice, stanozolol has been used for conditions such as osteoporosis, hypogonadism, and to promote weight gain after trauma or chronic infection. In bodybuilding and performance-enhancement settings, it is commonly referenced for cutting phases and pre-contest preparation, though such use falls outside approved medical indications.
Stanozolol is not aromatized to estrogen, which eliminates the risk of estrogen-related side effects such as gynecomastia and water retention. As a 17-alpha-alkylated compound, it is associated with hepatotoxicity and significant alterations in lipid profiles, including marked reductions in HDL cholesterol.
Stanoxyl 10 mg is supplied as an oral compressed tablet containing 10 mg of stanozolol per unit, packaged in a 100-tablet format by Kalpa Pharmaceuticals.
Stanozolol is an oral anabolic steroid characterized by a 17-alpha-alkylated structure, non-aromatization, and significant effects on lipid metabolism. Its profile differs from injectable compounds and other oral anabolics.
Stanozolol is a 17-alpha-alkylated compound, which allows it to survive first-pass metabolism in the liver and remain orally active. This structural modification is also responsible for its classification as a hepatotoxic compound, requiring periodic liver function monitoring during any use.
The compound has moderate anabolic effects and low binding affinity for the androgen receptor, but is a strong activator of androgen receptor-induced protein synthesis. Unlike testosterone, stanozolol is not aromatized to estrogen, so estrogenic side effects are not typically associated with its use.
Stanozolol is regulated as a Schedule III controlled substance in the United States. FDA-approved forms have been discontinued. Its use in athletics is prohibited by major anti-doping organizations.
Stanozolol has a half-life of approximately 9 hours. This allows for once or twice daily dosing in clinical settings, though non-medical contexts sometimes involve more frequent administration.
Kalpa Pharmaceuticals offers several oral anabolic preparations with different compounds, potencies, and intended profiles. The main distinctions involve hepatotoxicity, aromatization potential, and anabolic-to-androgenic ratios.
For those comparing oral options, Stanoxyl 50 offers the same active substance at a higher concentration per tablet. Dianoxyl 10 (methandienone) is a potent bulking oral but is aromatizable and associated with water retention. Anadroxyl (oxymetholone) is another potent mass-building oral, generally considered more hepatotoxic. Oxandroxyl 10 (oxandrolone) is a non-aromatizing oral often referenced for cutting, with a milder side effect profile.
The information below is provided for educational reference only. Stanozolol is a Schedule III controlled substance in the United States; medical use requires appropriate diagnosis, clinical supervision, and ongoing monitoring. Non-medical use falls outside approved indications.
In clinical practice, stanozolol has been studied at 6 mg per day in male weight lifters. The manufacturer's clinical information references dosing of 4–6 mg per day, administered one to three times daily. In non-medical bodybuilding contexts, stanozolol is commonly referenced in the range of 20–50 mg per day, though such use falls outside approved medical indications.
| Use Case | Common Reference Range | Frequency |
|---|---|---|
| Clinical study (weight lifters) | 6 mg per day | Once daily |
| Clinical (manufacturer) | 4–6 mg per day | 1–3 times daily |
| Bodybuilding (non-medical) | 20–50 mg per day | Divided doses |
| Cutting phase (non-medical) | 20–40 mg per day | Divided doses |
In non-medical bodybuilding contexts, stanozolol is commonly used during cutting phases to help preserve lean muscle while reducing body fat. It is often stacked with injectable testosterone preparations or other non-aromatizing compounds.
Cycle duration in non-medical use is typically limited to 4–6 weeks due to the compound's 17-alpha-alkylated structure and associated liver stress. Bloodwork and liver function monitoring are advised if any use occurs.
Stanozolol is associated with significant hepatotoxicity and marked reductions in HDL cholesterol. Clinical studies have shown that stanozolol at 6 mg per day reduced HDL-cholesterol by 33% and the HDL2 subfraction by 71% in male weight lifters. Aromatase inhibitors such as Arimixyl 1 mg are not relevant for stanozolol since it does not aromatize.
Blood pressure, liver enzymes, and lipid profiles should be monitored during any use. Joint discomfort is also commonly reported in non-medical contexts.
Stanozolol suppresses endogenous testosterone production. In non-medical bodybuilding contexts, post-cycle therapy is commonly referenced after any cycle involving this compound. Agents such as Clomixyl 50 mg or Nolvaxyl 20 mg are commonly discussed for this purpose.
PCT protocols vary based on cycle length, compounds used, and individual response. Bloodwork can help inform recovery strategy.
Dosing strategies and support protocols should be adjusted based on experience level, health status, and bloodwork where possible. The information above is for educational reference and does not constitute medical advice.
Stanozolol is a controlled anabolic steroid with significant hepatic, cardiovascular, and endocrine effects. Medical use requires appropriate diagnosis, clinical supervision, and ongoing monitoring.
Stanozolol lacks FDA approval for human use in the United States and is regulated as a Schedule III controlled substance. Anabolic steroids have not been shown to enhance athletic ability.
Non-medical use of stanozolol at supraphysiologic doses falls outside approved indications and can substantially increase exposure to hepatotoxic, cardiovascular, and androgenic adverse effects.
Stanozolol is a Schedule III controlled substance in the United States. Non-medical use is associated with serious health risks, including liver injury, cardiovascular events, and kidney damage.
Hepatotoxicity is a primary concern with stanozolol. As a 17-alpha-alkylated compound, it is associated with elevated liver enzymes, cholestatic jaundice, and other hepatic complications. Liver function tests should be monitored periodically during any use.
Cardiovascular effects include marked reductions in HDL cholesterol and increased LDL cholesterol. Clinical studies have shown that stanozolol at 6 mg per day reduced HDL-cholesterol by 33% and increased LDL cholesterol by 29%.
Kidney damage has been reported with stanozolol use. A 1994 case report described acute tubular necrosis confirmed by renal biopsy in a 26-year-old male related to stanozolol abuse. Animal studies have also shown that stanozolol administration significantly increases kidney damage markers in a dose-dependent manner.
Androgenic effects may include acne, oily skin, and suppression of endogenous testosterone production. In women, virilization signs may occur.
Stanozolol is contraindicated in men with known or suspected prostate or breast cancer, in women who are or may become pregnant, and in patients with hepatic dysfunction.
Pre-existing cardiovascular disease, liver disease, kidney disease, diabetes, and prostate conditions require careful evaluation before any consideration of stanozolol use. In children, stanozolol may cause premature closure of the epiphyses and should be avoided in those under 12 years of age.
Medically supervised stanozolol therapy would typically involve periodic liver function tests, lipid profile assessment, and monitoring of kidney function markers. Blood pressure and hematocrit should also be monitored.
Any use of stanozolol should be accompanied by appropriate monitoring and medical supervision where possible.
Store in a cool, dry place away from direct light and moisture. Keep tablets in the original packaging until use. Keep out of reach of children.
Stanoxyl 10 mg is supplied through the official Kalpa Pharmaceuticals distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the official Kalpa Pharmaceuticals distribution chain.
To verify your Stanoxyl 10 mg product, use the security code on the packaging and cross-check it on the Kalpa official site. Original Kalpa Pharmaceuticals presentation and packaging help reinforce product legitimacy and buyer confidence.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Proper storage conditions help preserve tablet integrity and stability throughout shelf life.
Store Stanoxyl 10 mg in a cool, dry place away from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the tablets.
Keep the tablets in their original packaging until use. Do not use if the packaging is damaged or if the tablets appear abnormal in color or texture.
Keep out of reach of children. Follow proper handling practices for oral medications.
Answers to common questions about Stanoxyl 10 mg, stanozolol, dosing, side effects, and product specifications.
Stanoxyl 10 mg contains stanozolol, which was historically used for conditions such as osteoporosis, hypogonadism, and to promote weight gain after trauma or chronic infection. In non-medical bodybuilding contexts, stanozolol is commonly referenced for cutting phases and lean muscle retention, though such use falls outside approved medical indications. FDA-approved forms have been discontinued.
In clinical practice, stanozolol has been studied at 6 mg per day in male weight lifters. The manufacturer's clinical information references dosing of 4–6 mg per day, administered one to three times daily. Non-medical use often involves more frequent administration to maintain stable blood levels.
Stanozolol suppresses endogenous testosterone production. In non-medical bodybuilding contexts, post-cycle therapy is commonly referenced after any cycle involving this compound. Agents such as Clomixyl 50 mg or Nolvaxyl 20 mg are commonly discussed for this purpose.
Stanozolol is a synthetic androgen that activates androgen receptor-induced protein synthesis and erythropoietin production. It promotes nitrogen retention and protein synthesis, contributing to lean muscle support. Unlike testosterone, it is not aromatized to estrogen.
Clinical studies in weight lifters examined effects over a six-week period, with significant changes in lipid profiles observed. In non-medical bodybuilding contexts, users often report noticeable effects within the first two weeks, though individual response varies.
There is no single oral steroid that is universally best. Stanozolol is commonly referenced for cutting phases due to its non-aromatizing profile. Other orals such as Dianoxyl 10, Anadroxyl, and Oxandroxyl 10 have different potency, side effect, and aromatization profiles.
Both stanozolol and methandienone are oral 17-alpha-alkylated anabolic steroids. Stanozolol does not aromatize and is more commonly referenced for cutting phases. Methandienone is aromatizable and is more commonly referenced for bulking, but is associated with water retention.
Stanozolol and oxandrolone are both oral 17-alpha-alkylated anabolic steroids that do not aromatize. Oxandrolone is generally considered milder in terms of androgenic side effects and hepatotoxicity. Stanozolol is more commonly referenced for lean, dry gains but may be associated with more joint discomfort and more pronounced lipid alterations.
In clinical practice, stanozolol has been studied at 6 mg per day in male weight lifters. A single 10 mg tablet would represent a higher dose than that studied clinically. In non-medical bodybuilding contexts, 20–50 mg per day is commonly referenced, with 10 mg per day considered a low-to-moderate dose.
Stanoxyl 10 mg is labeled at 10 mg of stanozolol per tablet. It is supplied in packs of 100 tablets, giving 1,000 mg of total labeled stanozolol content per pack.
Kidney damage has been reported with stanozolol use. A 1994 case report described acute tubular necrosis confirmed by renal biopsy in a 26-year-old male related to stanozolol abuse. Animal studies have also shown that stanozolol administration significantly increases kidney damage markers in a dose-dependent manner.
Laboratory testing information for Stanoxyl 10 mg is not currently available in this product listing. Kalpa Pharmaceuticals products are manufactured under pharmaceutical-grade conditions, but independent lab reports are not published for this specific product at this time.
Drug Class: Selective Estrogen Receptor Modulator (SERM)
Active Substance: Tamoxifen Citrate
Strength: 20 mg/tablet
Amount: 30 or 100 tablets
Active Life: 5–7 days
Average Dose: 10–40 mg/day
Liver Toxicity: Low
Aromatization Rate: None
Anabolic Rate: 0
Androgenic Rate: 0
Manufacturer: Kalpa Pharmaceuticals
You can order steroids from here without prescription. We will offer you the best and 100% original steroids. You wont need to hesitate about the authenticity because we don't sell fake products. We don't have the right to scam and play with your health, nobody does. So feel free to get steroids from our steroid shop. We have injectable steroids, oral steroids, post cycle therapy drugs, diuretics, fat-burners and so on. We will try our best to satisfy you and support you. Don't forget that you can always contact us if you are having any problem.
April 8, 2019
As for the stanoxyl, it was my first time with stanoxyl, so i kept the doses moderate. I ran 30mg for 5 weeks. It hardened me up and gave me some intense pumps. My joints were very sore, so i think ill stick to var in the future.